Overall, patient-derived TIL from CRC and CRLM contained generally 9.9% and 11.5% PD1hi and 13.0% and 11.0% LAG3+ CD8+ cells, respectively (Figure 6B). This evidence concerns the gene CD8A and colorectal carcinoma.